✦ LIBER ✦

Predictors of mortality after androgen-deprivation therapy in patients with rapidly rising prostate-specific antigen levels after local therapy for prostate cancer

✍ Scribed by Neesha A. Rodrigues; Ming-Hui Chen; William J. Catalona; Kimberly A. Roehl; Jerome P. Richie; Anthony V. D'Amico

Publisher: John Wiley and Sons
Year: 2006
Tongue: English
Weight: 156 KB
Volume: 107
Category: Article
ISSN: 0008-543X
DOI: 10.1002/cncr.22018

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Mitoxantrone in patients with prostate s

Mitoxantrone in patients with prostate specific antigen progression after local therapy for prostate carcinoma

✍ Robert S. DiPaola; Eric S. Chenven; Weichung J. Shih; Yong Lin; Peter Amenta; Su 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 294 KB 👁 2 views

Influence of body mass index on prostate

Influence of body mass index on prostate-specific antigen failure after androgen suppression and radiation therapy for localized prostate cancer

✍ Jason A. Efstathiou; Ming-Hui Chen; Andrew A. Renshaw; Marian J. Loffredo; Antho 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 112 KB 👁 1 views

## Abstract ## BACKGROUND Increasing body mass index (BMI) is associated with shorter time to prostate‐specific antigen (PSA) failure after radical prostatectomy. Whether BMI is associated with time to PSA failure was investigated in men treated with androgen suppression therapy (AST) and radiatio

Pretreatment prostate-specific antigen v

Pretreatment prostate-specific antigen velocity is associated with development of distant metastases and prostate cancer mortality in men treated with radiotherapy and androgen-deprivation therapy

✍ David Palma; Scott Tyldesley; Tom Pickles; for the Prostate Cohort Outcomes Init 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 135 KB 👁 1 views

## Abstract ## BACKGROUND In men with prostate cancer, pretreatment prostate‐specific antigen (PSA) velocity (PSAV) has been demonstrated as a predictor of biochemical and survival outcomes in patients undergoing radical prostatectomy (RP). The utility of pretreatment PSAV in predicting outcomes a

Efficacy of androgen deprivation therapy

Efficacy of androgen deprivation therapy (ADT) in patients with advanced prostate cancer : Association between Gleason score, prostate-specific antigen level, and prior ADT exposure with duration of ADT effect

✍ Robert W. Ross; Wanling Xie; Meredith M. Regan; Mark Pomerantz; Mari Nakabayashi 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 193 KB 👁 1 views

## Abstract ## BACKGROUND The purpose of this study was to compare predictive factors for the efficacy of androgen deprivation therapy (ADT) in men with hormone‐sensitive prostate cancer (HSPC) either with (M+) or without (M−) metastases. ## METHODS A cohort of prostate cancer patients was ident

Rapid rise of serum prostate specific an

Rapid rise of serum prostate specific antigen levels after discontinuation of the herbal therapy PC-SPES in patients with advanced prostate carcinoma : Report of four cases

✍ William K. Oh; Daniel J. George; Philip W. Kantoff 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 247 KB 👁 1 views

Biochemical outcome after radical prosta

Biochemical outcome after radical prostatectomy or external beam radiation therapy for patients with clinically localized prostate carcinoma in the prostate specific antigen era

✍ Anthony V. D'Amico; Richard Whittington; S. Bruce Malkowicz; Kerri Cote; Marian 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 92 KB 👁 1 views

## Abstract ## BACKGROUND To the authors' knowledge, consensus is lacking regarding the relative long‐term efficacy of radical prostatectomy (RP) versus conventional‐dose external beam radiation therapy (RT) in the treatment of patients with clinically localized prostate carcinoma. ## METHODS A